Tag: Pfizer

March 13, 2023

Pfizer Inc. has agreed to pay $43 billion for biotech Seagen Inc. SGEN 16.29%increase; green up pointing triangle and its pioneering class of targeted cancer drugs. Under the terms, Pfizer would pay $229 a share in cash, the drugmaker said […]

October 31, 2022

Rival drugmakers are seeking to upend Pfizer Inc.’s dominance of the $7 billion worldwide market for pneumonia vaccines, launching what is shaping up to be one of the industry’s fiercest battles. Merck & Co. has already introduced a new competitor […]

April 11, 2022

Vaccine makers Pfizer Inc. and Moderna Inc. named company outsiders as chief financial officers as they look to deploy some of the cash they have generated during the Covid-19 pandemic. New York-based Pfizer on Monday said David Denton will take […]

January 11, 2022

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a collaboration with Pfizer Inc. and global charitable foundation Wellcome to better understand the role of diagnostics in advancing antimicrobial stewardship practices around the world. […]

November 16, 2021

Pfizer Inc. is licensing its experimental Covid-19 antiviral to a global health organization in an effort to make the pill more readily available to people in low- and middle-income countries. Under the licensing agreement, the United Nations-backed Medicines Patent Pool […]

March 29, 2021

That is nearly twice the amount of the five billion vaccine doses of all types produced across the world before the pandemic struck. Even so, it is still less than the 11.5 billion doses of Covid-19 vaccine needed to meet […]

November 12, 2020

When Pfizer Inc. and BioNTech SE’s COVID-19 vaccine rolls off production lines, Shanghai Fosun Pharmaceutical Group Co. will be waiting to distribute it through a complex and costly system of deep-freeze airport warehouses, refrigerated vehicles and inoculation points across China. […]